Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Articles

Research Type: Articles

Sort 1 results by:

Filter Applied. Clear All

Latest Posts

September 16, 2026 Examining women’s experiences with medication abortion: a critical inquiry of women’s online narratives post-Dobbs Examining women’s experiences with medication abortion: a critical inquiry of women’s online narratives post-Dobbs September 15, 2026 New Study: Abortion, Natural Pregnancy Loss Are Risk Factors for Future Maternal Complications New Study: Abortion, Natural Pregnancy Loss Are Risk Factors for Future Maternal Complications September 15, 2026 Fact Sheet: Fetal Development Education in the United States Fact Sheet: Fetal Development Education in the United States
Reset All Filters
Maternal & Public Health

Abortion Reporting: Oregon (2022)

A total of 8,672 abortions were reported in Oregon in 2022, an increase of 22% from 2021.

Maternal & Public Health

CLI Authors’ Responses to Sage Concerns and Retractions

On February 5, 2024, Sage Publications retracted three peer-reviewed articles authored by affiliates of the Charlotte Lozier Institute. Prior to these retractions, Sage issued an expression of concern against the first of the three articles in July of 2023. Reproduced here are the authors’ initial response to Sage’s notice informing CLI of its intention to issue an expression of concern, as well as the authors’ subsequent response to the official retractions.

CLI Scholars React to Nature Medicine Study
Abortion Drugs

CLI Scholars React to Nature Medicine Study

Following the release of a study in Nature Medicine, which discussed the “safety and effectiveness” of abortion drugs acquired through telehealth, Tessa Longbons Cox, senior research associate at the Charlotte Lozier Institute, made the following statement:

Charlotte Lozier Institute Responses to Sage Retractions
General

Charlotte Lozier Institute Responses to Sage Retractions

The Charlotte Lozier Institute (CLI) and associate scholars are facing an unprecedented attack on our research. We believe that because our research has been widely read and cited, including in prominent legal contexts, we are now subject to unprovoked and partisan assault. Sage Publishing, an academic publishing company, retracted three of our studies on February 5, 2024. This action is meritless because, among other things, Sage to this day has advanced no legitimate objection to any findings of the studies.

Maternal & Public Health

Abortion Reporting: Pennsylvania (2022)

Pennsylvania’s 2022 abortion report was published online by the Pennsylvania Department of Health in December 2023. The report shows that abortions increased from the previous year.

Maternal & Public Health

Abortion Reporting: Idaho (2022)

The Idaho Department of Health and Welfare released their annual vital statistics report, showing that abortions declined in 2022 from the previous year.

Maternal & Public Health

Abortion Reporting: Arizona (2022)

Arizona’s 2022 abortion report was published online by the Arizona Department of Health Services in December 2023.

Fetal Tissue, Stem Cells & Bioethics

Stopping the Pain and Saving Lives: Successful Treatments for Sickle Cell Disease

The U.S. Food and Drug Administration (FDA) recently approved not just one, but two new gene therapies for sickle cell disease. The success of adult stem cell therapies continues to demonstrate that the progress of science and medicine need not rely on ethically compromised research and treatment approaches.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image